Regen Biologics Company Profile - Dec 21, 2010

Document Sample
Regen Biologics Company Profile - Dec 21, 2010 Powered By Docstoc
					Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Regen Biologics, Inc.
                                                                                       440 Wheelers Farms Road
                                                                                       Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in U.S. Dollars

                                 Wright Quality Rating:LLNN                                Key Data

   ReGen Biologics, Inc. (ReGen) is a development stage orthopedic products company        Ticker:
   that develops, manufactures and markets tissue growth and repair products for           RGBO
   United States and global markets. The Company's collagen matrix technology
   includes applications in orthopedics, general surgery, spine, cardiovascular and drug   2008 Sales:
   delivery. Some of these applications are marketable while others are in various
                                                                                           1,374,000
   stages of development. ReGen's first approved product using its collagen matrix
   technology is the Menaflex collagen meniscus implant device (also known as the
   CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey,       Major Industry:
   and the Republic of South Africa, through the Company's subsidiary, ReGen Biologics     Drugs, Cosmetics & Health
   AG.                                                                                     Care
                       Stock Chart                                 Officers
                                                         Chairman, President, Chief        Sub Industry:
                                                         Executive & Chief Financial       Medical, Surgical & Dental
                                                                   Officer                 Suppliers
                                                            Dr. Gerald E. Bisbee Jr.
                                                                                           Country:
                                                                                           United States

                                                                                           Currency:
                                                                                           U.S. Dollars

                                                                                           Fiscal Year Ends:
                                                                                           December

                                                                                           Employees
                                                                                           20

                                                                                           Exchanges:
                                                                                           OTC

            Stock Price (12/17/2010): 0.03                                             
				
DOCUMENT INFO
Description: ReGen Biologics, Inc. (ReGen) is a development stage orthopedic products company that develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. ReGen's first approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company's subsidiary, ReGen Biologics AG.
BUY THIS DOCUMENT NOW PRICE: $24.95 100% MONEY BACK GUARANTEED
PARTNER Wright Investors' Service
Wright Investors' Service is an internationally recognized investment management and financial advisory firm headquartered in Milford, Connecticut. For more than 40 years, Wright has used well-defined and sophisticated investment strategies to help institutions, plan sponsors, bank trust departments, trust companies and individual investors achieve their financial objectives through a sensible approach to managing assets that balances risk and return.